Digitisation | January 02, 2023
Quantori partners with Databricks to accelerate data-driven innovation in life sciences
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
Cipla and Ethris partner for the development of mRNA-based therapies
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
Fulvestrant Injection, 250 mg/5 mL, has an estimated market size of US $71 million for twelve months ending Sep 2022 according to IQVIA
WHO made a strong recommendation for nirmatrelvir and ritonavir for mild and moderate COVID-19 patients at highest risk of hospital admission
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Subscribe To Our Newsletter & Stay Updated
